News
Extera Partners hires life sciences vet Bernitz
August 23, 2010 8:31 am | by Mass High Tech: The Journal of New England Technology | CommentsSteve Bernitz has taken the role of general partner at Cambridge-based Extera Partners, a life sciences-focused firm specializing in partnerships, acquisitions and new product commercialization.
Public Workshop - Medical Device User Fee Program Public Meeting, September 14, 2010
August 23, 2010 7:37 am | by U.S. Food & Drug Administration | CommentsThe FDA is is announcing a public meeting on the reauthorization of the medical device user fee program. The current legislative authority for the medical device user fee program expires in September 2012 and new legislation will be required for FDA...
Biomerica gets European OK for dog allergy test
August 23, 2010 6:45 am | by The Associated Press | CommentsBiomerica Inc. said Monday it has received European regulatory approval to sell a home test that consumers can use to determine if they are allergic to dogs.The biomedical company will sell the product through drug stores and other retailers in the European Union under the Fortel Dog allergy...
Covalon Technology third-quarter loss tightens as operating expenses fall
August 23, 2010 5:45 am | by The Associated Press | CommentsCovalon Technologies Ltd. (TSXV:COV) says its third-quarter loss was cut in half, as the medical technology developer reduced costs by 40 per cent compared with the same period last year.Covalon's net loss was $647,223 in the three months ended June 30, down from $1.2 million in the...
Federal Register: Food and Drug Administration Clinical Trial Requirements, Regulations, Compliance, and Good Clinical Practice; Public Workshop
August 23, 2010 5:32 am | by U.S. Food & Drug Administration | CommentsThe public workshop on FDA's clinical trial requirements is designed to aid the clinical research professional's understanding of the mission, responsibilities, and authority of FDA and to facilitate interaction with FDA representatives. The program will
Federal Register: Public Workshop on Medical Devices and Nanotechnology: Manufacturing, Characterization, and Biocompatibility Considerations
August 23, 2010 5:32 am | by U.S. Food & Drug Administration | CommentsThe purpose of this workshop is to obtain information on manufacturing, characterization, and biocompatibility evaluation of medical devices containing or utilizing nanomaterials and nanostructures, including diagnostics. FDA is seeking input on these...
Taligen boosts Series B round by $10M
August 23, 2010 5:32 am | by Mass High Tech: The Journal of New England Technology | CommentsCambridge biotech Taligen Therapeutics Inc. has added on to its Series B Round with an additional $10 million, bringing the amount up to $36 million of a planned $65 million second round.
Community Healthcare Workers and Patients Benefit From the Panasonic Toughbook CF-C1
August 23, 2010 4:32 am | by RealWire | CommentsUK. 23RD AUGUST 2010: The Panasonic Toughbook CF-C1 will bring major benefits to community healthcare workers and patients alike, claimed NHS leaders speaking at BT's unveiling of the Toughbook as a key component of its Mobile Health Worker solution.The CF-C1, a rugged yet lightweight...
Cost of prostate cancer care varies with initial treatment choice
August 22, 2010 10:31 pm | by EurekAlert | Comments(American Cancer Society) A new analysis has found that short-term and long-term costs of prostate cancer care vary considerably based on which treatment strategy a man initially receives.
Rectal cancer rates are rising in young individuals
August 22, 2010 10:31 pm | by EurekAlert | Comments(American Cancer Society) A new analysis has found that while colon cancer rates have remained steady over the past several decades among people under the age of 40, rectal cancer rates are increasing in this population across races and in both sexes.
Hospira Japan Receives Approval for New Indication for 'Precedex IVâ„¢ 200ug'
August 22, 2010 8:34 pm | by Bio-Medicine.Org | CommentsOSAKA, Japan, Aug. 22 /- Hospira Japan Co., Ltd. today announced it has received an approval for the long-term (greater than 24 hour) use of the sedative "Precedex IV™200ug" (generic name: dexmedetomidine hydrochloride). This approval follows Hospira's first launches earlier this...
New 'Heroes of Chemistry' invented medicines that help millions of people
August 22, 2010 4:34 pm | by EurekAlert | Comments(American Chemical Society) It's a tale of two pills: One that helps millions of people with diabetes maintain normal blood sugar levels and another that helps millions in their effort to quit smoking. The two teams that invented these potentially life-saving drugs -- Januvia and Chantix...
Electrifying findings: New ways of boosting healthful antioxidant levels in potatoes
August 22, 2010 12:33 pm | by EurekAlert | Comments(American Chemical Society) Scientists in Japan are busy zapping potatoes and, as a result, the fifth most popular food consumed around the world may one day become an even more healthful vegetable. The researchers reported their results at the 240th National Meeting of the...
Worldwide shortage of isotopes for medical imaging could threaten quality of patient care
August 22, 2010 6:33 am | by EurekAlert | Comments(American Chemical Society) Twenty million medical scans and treatments are done each year that require radioactive isotopes and scientists today described a global shortage of these life-saving materials that could jeopardize patient care and drive-up health-care costs. They spoke...
Device Companies Are Getting Hit With False Patenting Lawsuits
August 20, 2010 1:33 pm | by U.S. Food & Drug Administration | CommentsA new cottage industry of suing companies for labeling their products with expired patents has emerged seemingly overnight and has the potential to inflict significant financial damage on the device industry.
